<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Document</title>
</head>

<body>
    Singapore

    <h2>Integrated Shield Plan coverage for hospitalisation due to COVID-19 vaccine complications extended to end-2022
    </h2>

    <div>
        <img src="https://onecms-res.cloudinary.com/image/upload/s--RArkqmS7--/c_fill%2Cg_auto%2Ch_468%2Cw_830/f_auto%2Cq_auto/singapore-covid-19-vaccine-7.jpg?itok=w2a9j7aw"
            alt="">
        <p>
            A healthcare worker at National Centre for Infectious Diseases prepares to administer one of the first doses
            of the COVID-19 vaccine in Singapore on Dec 30, 2020.
        </p>
    </div>

    <p>
        SINGAPORE: The seven insurers offering Integrated Shield Plans (IP) have extended their coverage of
        hospitalisation
        resulting from COVID-19 vaccine complications until Dec 31, 2022, said the Life Insurance Association, Singapore
        (LIA Singapore).
    </p>
    <p>
        The <a href="">special coverage</a> was first announced last January and was to have ended on Dec 31, 2021.
    </p>
    <p>
        The extended coverage will continue to apply to all IP policyholders who received COVID-19 vaccines under the
        national vaccination programme, as well as those approved by the World Health Organisation (WHO) under its
        emergency
        use listing and administered in Singapore under the special access route.
    </p>
</body>

</html>